Close
CDMO Safety Testing 2026
Novotech

RSSL announces new state-of-the-art facility opening as part of ambitious expansion plan

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

BeOne Signs $2B Trispecific Antibody Deal with Huahui Health

BeOne Medicines has entered into a high-value agreement with...

Quantum Machine Learning in Pharma Research Growth

The convergence of artificial intelligence and quantum processing is opening new avenues for rapid discovery and innovation within the life sciences. By utilizing advanced mathematical models that operate across multi-dimensional datasets, researchers can now identify complex biological patterns and predict molecular behaviors with a speed that surpasses traditional computational methods. This transformation is accelerating the development of novel therapies and providing deeper insights into disease mechanisms, fundamentally altering the trajectory of pharmaceutical research and development.
- Advertisement -

RSSL, a cutting-edge food and pharmaceutical contract research organisation announced the opening of its new state-of-the-art analytical testing facility on the University of Reading Whiteknights campus, as part of an ambitious expansion plan. The new facility will increase capacity to aid RSSL in meeting the growing demand of its global client base across the life science, healthcare, food, and consumer goods sectors.

The expansion has been driven by RSSLโ€™s recent significant organic growth and successful strategic partnerships, which have enabled it to double its revenue since 2016. With a base of over 3,000 clients in 60 countries across the European, US, LATAM, and APAC markets, the new facility will accelerate turnaround times and deliver efficiencies for RSSLโ€™s clients around the world.

The new facility will add an extra 26,000 sq. ft. of working laboratory space with new technical capabilities to complement RSSLโ€™s existing UKAS-accredited, MHRA- and FDA-approved facilities. To support this bold growth strategy, RSSL is also making a major investment into expanding its workforce from 350 to over 500 in the next three years, by doubling the number of scientists in its team. Together, these investments will enable RSSL to continue collaborating with its clients to provide indispensable research and meet the increasing need for specialist knowledge within its key sectors.

Jacinta George, Managing Director, RSSL said: โ€œOur clients are at the forefront of innovation within their industries, working on projects ranging from sustainable food solutions to next-generation therapeutics. With this exciting new expansion, we will be able to continue supporting them to develop high-quality, safe products that meet complex regulatory requirements and consumer needs.

George added: โ€œBy expanding RSSLโ€™s capacity and capabilities, the addition of this new facility reinforces our commitment to science, innovation and collaboration and will enable us to meet evolving industry needs and drive vital progress across a diverse range of sectors.โ€

Professor Parveen Yaqoob OBE, Deputy Vice-Chancellor of the University of Reading, and Pro-Vice-Chancellor for Research and Innovation, said: โ€œFor cutting-edge science to thrive, we need skilled people, world-class facilities, and a spirit of collaboration and discovery. These shared values are helping both the University of Reading and RSSL to grow from our shared Whiteknights campus, and we look forward to continuing our successful partnership into the future.โ€

 

Latest stories

Related stories

BeOne Signs $2B Trispecific Antibody Deal with Huahui Health

BeOne Medicines has entered into a high-value agreement with...

Quantum Machine Learning in Pharma Research Growth

The convergence of artificial intelligence and quantum processing is opening new avenues for rapid discovery and innovation within the life sciences. By utilizing advanced mathematical models that operate across multi-dimensional datasets, researchers can now identify complex biological patterns and predict molecular behaviors with a speed that surpasses traditional computational methods. This transformation is accelerating the development of novel therapies and providing deeper insights into disease mechanisms, fundamentally altering the trajectory of pharmaceutical research and development.

Quantum Sensors Enabling Advanced Drug Diagnostics

The landscape of medical diagnostics is being reshaped by the introduction of sensing technologies that operate with atomic-level sensitivity. By providing high-fidelity measurements and real-time data, these tools allow for the detection of subtle biological changes and chemical markers that were previously invisible to conventional equipment. This advancement is enhancing the precision of drug testing and clinical monitoring, leading to earlier disease detection and more effective therapeutic interventions across the global healthcare spectrum.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป